Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease. The study has enrolled a total of 65 participants in the US, Europe and Australia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback